PMID- 19443297 OWN - NLM STAT- MEDLINE DCOM- 20091006 LR - 20161013 IS - 0929-6646 (Print) IS - 0929-6646 (Linking) VI - 108 IP - 5 DP - 2009 May TI - HLA-DR-matched parental donors for allogeneic hematopoietic stem cell transplantation in patients with high-risk acute leukemia. PG - 423-7 LID - 10.1016/S0929-6646(09)60087-5 [doi] AB - The immunomodulating effect of human leukocyte antigen (HLA)-DR and the central role of CD4 T cells in alloimmunity provide clues suggesting that HLA-DR-matched, partially mismatched related donors could be feasible alternative donors of allogeneic hematopoietic stem cells for transplantations (allo-HSCT). We describe our experience with allo-HSCT in eight patients with high-risk acute leukemia; donors included one of each of the parents. Among the eight patients, seven were identical HLA-DR matches with the donors. The stem cells were not manipulated in vitro. Graft-versus-host disease (GVHD) prophylaxis consisted of antithymocyte globulin, cyclosporine, and methotrexate. All patients had successful trilineage engraftment. Only one patient had grade 2-4 acute GVHD. Two patients died before day +100 due to complications. At the end of follow-up, four patients had survived for 18-48 months and three are alive and without relapse. Our results suggest that HLA-DR fully-matched parents are feasible alternative donors for allo-HSCT in patients with high-risk acute leukemia under an intensive conditioning regimen. FAU - Wu, Shang-Ju AU - Wu SJ AD - Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan. FAU - Yao, Ming AU - Yao M FAU - Tang, Jih-Luh AU - Tang JL FAU - Ko, Bo-Sheng AU - Ko BS FAU - Tien, Hwei-Fang AU - Tien HF FAU - Chen, Yao-Chang AU - Chen YC LA - eng PT - Journal Article PL - Singapore TA - J Formos Med Assoc JT - Journal of the Formosan Medical Association = Taiwan yi zhi JID - 9214933 RN - 0 (HLA-DR Antigens) SB - IM MH - Acute Disease MH - Adolescent MH - Adult MH - Female MH - Graft vs Host Disease/etiology MH - HLA-DR Antigens/*immunology MH - *Hematopoietic Stem Cell Transplantation MH - Humans MH - Leukemia/mortality/*therapy MH - *Living Donors MH - Male MH - *Parents MH - Transplantation, Homologous EDAT- 2009/05/16 09:00 MHDA- 2009/10/07 06:00 CRDT- 2009/05/16 09:00 PHST- 2009/05/16 09:00 [entrez] PHST- 2009/05/16 09:00 [pubmed] PHST- 2009/10/07 06:00 [medline] AID - S0929-6646(09)60087-5 [pii] AID - 10.1016/S0929-6646(09)60087-5 [doi] PST - ppublish SO - J Formos Med Assoc. 2009 May;108(5):423-7. doi: 10.1016/S0929-6646(09)60087-5.